Oncología médica
Especialidad
University of Sussex
Brighton, Reino UnidoPublicaciones en colaboración con investigadores/as de University of Sussex (4)
2017
-
Long-term follow-up of The Intergroup Exemestane Study
Journal of Clinical Oncology, Vol. 35, Núm. 22, pp. 2507-2514
2013
-
Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): An open-label randomised study
The Lancet Oncology, Vol. 14, Núm. 10, pp. 962-970
2007
-
Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
Lancet, Vol. 369, Núm. 9561, pp. 559-570
2004
-
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
New England Journal of Medicine, Vol. 350, Núm. 11, pp. 1081-1092